zeuss semaglutide Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry, expanding patient access to GLP-1 therapy. #Zydus #ZydusGroup #SemaglutideInjection #GLP1Therapy Will There Be A 'Blood

Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604

Figure 1 5.1 Promotion of angiogenesis and endothelial progenitor cell function Endothelial progenitor cells (EPCs) play a pivotal role in endothelial repair and post-ischemic angiogenesis

GLP-1 also delays gastric emptying (digestion) and decreases secretion of glucagon, another hormone involved in regulating blood glucose

Also used in some cases of heart failure

Theyll help you find the best option for your condition, lifestyle, and budget